首页|SCC-Ag、Cath-D和CA125诊断宫颈鳞癌及转移价值

SCC-Ag、Cath-D和CA125诊断宫颈鳞癌及转移价值

扫码查看
目的 评价鳞状细胞癌抗原(SCC-Ag)、组织蛋白酶D(Cath-D)联合糖类抗原CA125诊断宫颈鳞癌及其转移的效果.方法 选择首次诊治宫颈鳞癌病人51例(宫颈癌组)、同时期同年龄段宫颈上皮内瘤变30例(CIN组)和健康体检者30例(对照组),检测并比较3组SCC-Ag、Cath-D和CA125的水平.以病理诊断或(和)影像学分期为标准,应用受试者工作特征(ROC)曲线评价SCC-Ag、Cath-D和CA125单独以及联合诊断宫颈癌及其转移的效能.结果 与对照组和CIN组比较,宫颈癌组SCC-Ag、Cath-D和CA125水平升高,差异有显著性(F=17.693~51.815,P<0.05);宫颈癌转移组SCC-Ag、Cath-D和CA125的水平显著高于未转移组(t=2.043~2.095,P<0.05).SCC-Ag、Cath-D和CA125联合诊断宫颈癌的效能显著高于单独诊断(AUC分别为0.94、0.78、0.87和0.82),联合诊断时的最佳截点为:SCC-Ag> 1.49 μg/L,Cath-D> 10.83 ng/L,CA125>18.95 kU/L.SCC-Ag、Cath-D和CA125联合预测宫颈癌转移的效能显著高于单独诊断(AUC分别为0.91、0.70、0.83和0.80),联合诊断时的最佳截点为:SCC-Ag> 1.96 μg/L,Cath-D> 13.53 ng/L,CA125>22.42 kU/L.结论 SCC-Ag、Cath-D和CA125对于宫颈鳞癌的诊断以及转移预测具有较高的价值.
DIAGNOSTIC VALUE OF SCC-AG, CATH-D, AND CA125 FOR CERVICAL SQUAMOUS CELL CARCINOMA AND ITS METASTASIS
Objective To evaluate the value of combined measurement of squamous cell carcinoma antigen (SCC-Ag),cathepsin D (Cath-D),and carbohydrate antigen (CA125) in the diagnosis of cervical squamous cell carcinoma and its metastasis.Methods Fifty-one patients with firstly diagnosed cervical squamous cell carcinoma (cervical cancer group),as well as 30 patients with cervical intraepithelial neoplasia (CIN group) and 30 healthy controls in the same age and in the same period,were enrolled for this study.The levels of SCC-Ag,Cath-D,and CA125 were determined and compared between the three groups.Based on pathological diagnosis and/or imaging staging,the receiver operating characteristic (ROC) curve was used to evaluate the efficacy of SCC-Ag,Cath-D,and CA125 alone and in combination for the diagnosis of cervical cancer and its metastasis.Results The levels of SCC-Ag,Cath-D,and CA125 were significantly higher in the cervical cancer group than in the control group or CIN group (F=17.693-51.815,P<0.05).The subgroup analysis showed that the levels of SCC-Ag,Cath-D,and CA125 in the metastatic group were significantly higher than those in non-metastatic group (t =2.043-2.095,P <0.05).The diagnostic efficiency of combined measurement of SCC-Ag,Cath-D,and CA125 was significantly higher than that of SCC-Ag,Cath-D,or CA125 alone in the diagnosis for cervical cancer (area under the ROC curve (AUC)=0.94,0.78,0.87 and 0.82,respectively),and the optimal cut-off point for combined measurement was SCC-Ag >1.49μg/L,Cath-D >10.83 ng/L,and CA125 >18.95 kU/L.The diagnostic efficiency of combined measurement of SCC-Ag,Cath-D,and CA125 was significantly higher than that of SCC-Ag,Cath-D,or CA125 alone in the diagnosis of the metastasis of cervical cancer (AUC=0.91,0.70,0.83 and 0.80,respectively),and the optimal cut-off point was SCC-Ag >1.96 μg/L,Cath-D >13.53 ng/L,and CA125 >22.42 kU/L.Conclusion A combination of SCC-Ag,Cath-D,and CA125 has a high value in the diagnosis of cervical squamous cell carcinoma and the prediction of tumor metastasis.

uterine cervical neoplasmscarcinoma, squamous cellneoplasm metastasisearly diagnosis

钟昌宝、梁振达、李南

展开 >

海口市中医医院检验科,海南海口 570102

宫颈肿瘤 癌,鳞状细胞 肿瘤转移 早期诊断

海南省自然科学基金资助项目

2014812178

2017

齐鲁医学杂志
青岛大学医学院

齐鲁医学杂志

影响因子:0.609
ISSN:1008-0341
年,卷(期):2017.32(5)
  • 3
  • 13